Holdings (as at 2026-05-15)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.98%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2026-05-15)
Security Name % of Net Assets
Corcept Therapeutics Inc. 4.35%
Axsome Therapeutics, Inc. 4.13%
Veracyte, Inc. 4.00%
Neurocrine Biosciences, Inc. 3.97%
Krystal Biotech, Inc. 3.82%
Illumina, Inc. 3.81%
Arrowhead Pharmaceuticals, Inc. 3.80%
Bruker Corporation 3.69%
Exelixis, Inc. 3.66%
Alkermes Plc 3.63%
Biogen Inc. 3.61%
NeoGenomics, Inc. 3.46%
Vertex Pharmaceuticals Incorporated 3.24%
argenx SE (ADR) 3.23%
Incyte Corporation 3.21%
United Therapeutics Corporation 3.21%
Halozyme Therapeutics, Inc. 3.20%
Natera, Inc. 3.12%
BioMarin Pharmaceutical Inc. 3.07%
BeOne Medicines Ltd. (ADR) 3.06%
Genmab A/S (ADR) 3.04%
BioNTech SE (ADR) 3.03%
Amgen Inc. 3.01%
Gilead Sciences, Inc. 3.01%
Regeneron Pharmaceuticals, Inc. 3.01%
Alnylam Pharmaceuticals, Inc. 2.88%
Repligen Corporation 2.77%
ADMA Biologics, Inc. 2.76%
Sarepta Therapeutics, Inc. 2.68%
Bio-Techne Corporation 2.52%
Dreyfus Government Cash Management (Institutional Shares) 0.04%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.